Home

Malheur Préférence graphique prolastin c dosing calculator Dévier origine éruption

PROLASTIN®-C Liquid: Trusted Therapy for Alpha1-Antitrypsin Deficiency
PROLASTIN®-C Liquid: Trusted Therapy for Alpha1-Antitrypsin Deficiency

These highlights do not include all the information needed to use PROLASTIN ®-C safely and effectively. See full prescribing information for PROLASTIN-C.  PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]) Lyophilized Powder for  Solution for Intravenous ...
These highlights do not include all the information needed to use PROLASTIN ®-C safely and effectively. See full prescribing information for PROLASTIN-C. PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]) Lyophilized Powder for Solution for Intravenous ...

Medicare Advantage Medical Benefit Drug Policy
Medicare Advantage Medical Benefit Drug Policy

Prolastin-C for the Treatment of Alpha1-Antitrypsin Deficiency: A Review of  Clinical and Cost- Effectiveness
Prolastin-C for the Treatment of Alpha1-Antitrypsin Deficiency: A Review of Clinical and Cost- Effectiveness

PROLASTIN-C Liquid | Dosing and Administration for Patients with Alpha-1
PROLASTIN-C Liquid | Dosing and Administration for Patients with Alpha-1

Long-term safety of Prolastin®-C, an alpha1-proteinase inhibitor, in  Japanese patients with alpha1-antitrypsin deficiency - ScienceDirect
Long-term safety of Prolastin®-C, an alpha1-proteinase inhibitor, in Japanese patients with alpha1-antitrypsin deficiency - ScienceDirect

Pharmacokinetic comparability of Prolastin®-C to Prolastin® in  alpha1-antitrypsin deficiency: a randomized study | BMC Clinical  Pharmacology | Full Text
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha1-antitrypsin deficiency: a randomized study | BMC Clinical Pharmacology | Full Text

Medicare Advantage Medical Benefit Drug Policy
Medicare Advantage Medical Benefit Drug Policy

COPD due to alpha-1 Diagnostic Tests | PROLASTIN-C Liquid
COPD due to alpha-1 Diagnostic Tests | PROLASTIN-C Liquid

AusPAR Attachment 2: Extract from the Clinical Evaluation Report for  Alpha1-proteinase inhibitor (Human)
AusPAR Attachment 2: Extract from the Clinical Evaluation Report for Alpha1-proteinase inhibitor (Human)

Summary Basis for Regulatory Action - Prolastin-C
Summary Basis for Regulatory Action - Prolastin-C

PROLASTIN-C Liquid | Augmentation Therapy for Patients with Alpha-1
PROLASTIN-C Liquid | Augmentation Therapy for Patients with Alpha-1

These highlights do not include all the information needed to use PROLASTIN- C LIQUID safely and effectively. See full prescribing information for  PROLASTIN-C LIQUID. PROLASTIN-C LIQUID (Alpha1-Proteinase Inhibitor  [Human])Solution for Intravenous ...
These highlights do not include all the information needed to use PROLASTIN- C LIQUID safely and effectively. See full prescribing information for PROLASTIN-C LIQUID. PROLASTIN-C LIQUID (Alpha1-Proteinase Inhibitor [Human])Solution for Intravenous ...

Package Insert - Prolastin-C
Package Insert - Prolastin-C

AusPAR Attachment 2: Extract from the Clinical Evaluation Report for  Alpha1-proteinase inhibitor (Human)
AusPAR Attachment 2: Extract from the Clinical Evaluation Report for Alpha1-proteinase inhibitor (Human)

These highlights do not include all the information needed to use PROLASTIN- C LIQUID safely and effectively. See full prescribing information for  PROLASTIN-C LIQUID. PROLASTIN-C LIQUID (Alpha1-Proteinase Inhibitor  [Human])Solution for Intravenous ...
These highlights do not include all the information needed to use PROLASTIN- C LIQUID safely and effectively. See full prescribing information for PROLASTIN-C LIQUID. PROLASTIN-C LIQUID (Alpha1-Proteinase Inhibitor [Human])Solution for Intravenous ...

AusPAR Attachment 1: Product Information for Alpha1-proteinase inhibitor  (Human)
AusPAR Attachment 1: Product Information for Alpha1-proteinase inhibitor (Human)

PROLASTIN-C Liquid | Dosing and Administration for Patients with Alpha-1
PROLASTIN-C Liquid | Dosing and Administration for Patients with Alpha-1

These highlights do not include all the information needed to use PROLASTIN ®-C safely and effectively. See full prescribing information for PROLASTIN-C.  PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]) Lyophilized Powder for  Solution for Intravenous ...
These highlights do not include all the information needed to use PROLASTIN ®-C safely and effectively. See full prescribing information for PROLASTIN-C. PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]) Lyophilized Powder for Solution for Intravenous ...

Clinical Policy: Alpha1-Proteinase Inhibitors (Aralast NP, Glassia,  Prolastin-C, Zemaira)
Clinical Policy: Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira)

PROLASTIN-C Liquid | Dosing and Administration for Patients with Alpha-1
PROLASTIN-C Liquid | Dosing and Administration for Patients with Alpha-1

Summary Basis for Regulatory Action - Prolastin-C
Summary Basis for Regulatory Action - Prolastin-C

Pharmacokinetic comparability of Prolastin®-C to Prolastin® in  alpha1-antitrypsin deficiency: a randomized study | BMC Clinical  Pharmacology | Full Text
Pharmacokinetic comparability of Prolastin®-C to Prolastin® in alpha1-antitrypsin deficiency: a randomized study | BMC Clinical Pharmacology | Full Text